Dr. Sarah Elizabeth Belden, DO

Dr. Belden practices at Aspire Dermatology in Middletown, Rhode Island.

Dr. Belden's NPI, 1356753974, was assigned on June 2, 2014. Dr. Belden graduated from UNE College of Osteopathic Medicine in 2014. Dr. Belden holds Rhode Island license DO00923.

Dr. Belden's primary practice is Aspire Dermatology, at 102 Valley Rd, Middletown, RI 02842 in Newport County. The practice phone is (401) 239-1800.

Dr. Belden's primary practice is Aspire Dermatology in Middletown, Rhode Island. Dr. Belden is also affiliated with The Miriam Hospital. The medical group on file is Aspire Dermatology. Dmand AI also links Dr. Belden to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Belden practices, 3 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Belden's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Belden is board certified in dermatology by the American Board of Dermatology. Dr. Belden is licensed in Rhode Island.

Dmand AI lists acute skin infection, benign or precancerous skin growths, cold sores or genital herpes, contact dermatitis, facial skin infection, hives, itchy rashes and joint cyst among the conditions Dr. Belden treats.

CMS data shows 2,238 Medicare services from Dr. Belden across 18 procedure codes in 2024, for 612 Medicare patients. Medicare paid $100,963 for them. Every service was in an office.

CMS counts 612 Medicare patients who saw Dr. Belden in 2024. The largest group is 65 to 74, with 281 patients. 75% of them have high cholesterol, and 72% have high blood pressure. 4% are also on Medicaid. Their average risk score is 1.03, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Belden's median patient age at 63, with 61% women.

In 2024, Dr. Belden wrote 1,801 Medicare Part D claims for 687 patients. 94% of them were for generic drugs. CMS names the drug for 1,656 of them, across 22 drugs with 11 or more claims each, at $40,441 in total drug cost. In 2023, CMS named 1,535 claims across 23 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Belden for performance year 2024, reported as part of a group. Dr. Belden accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 1,092 procedures of removal of skin lesions by Dr. Belden, more than 94% of the clinicians it reports for that procedure.

Dmand AI links 4 papers to Dr. Belden, published from 2010 to 2017. The most frequent topics are Melanoma. Dr. Belden's most frequent co-authors are Richard L. Averitte, MD and Stacey J. Pilkington, DO.

CMS Open Payments shows 195 general payments to Dr. Belden from 24 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Pfizer Inc. paid the most, $662.

Dr. Belden graduated from UNE College of Osteopathic Medicine in 2014. Dr. Belden is a member of AAD.

Dr. Belden is in network with 17 carriers, including Aetna, Excellus BlueCross BlueShield and United Healthcare. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.